Draft Infected Blood Compensation Scheme Regulations 2025
(Limited Text - Ministerial Extracts only)
Read Full debate
The Paymaster General and Minister for the Cabinet Office (Nick Thomas-Symonds)
I beg to move,
That the Committee has considered the draft Infected Blood Compensation Scheme Regulations 2025.
It is a pleasure to serve under your chairmanship, Sir Edward. Let me first address the reason we are here today. The infected blood scandal was a profound failure of the state. It is hard to conceive the scale of the damage done and the incredible suffering of all those impacted. It is important that those people remain at the forefront of our minds. It is for them that we must do everything in our power to rectify this injustice, restore trust in the state and demonstrate that we will not allow such failures to happen again.
This scandal was allowed to go unaddressed for generations, and the onus is on us to rebuild relationships and support those impacted as they progress through the next chapter of their journey. That is why in the autumn Budget, we set aside £11.8 billion to compensate people who are infected and affected by the infected blood scandal. It is, rightly, one of the largest compensation schemes in our country’s history.
The compensation scheme was first established in August last year by regulations approved by the House. The scheme is a tariff-based compensation scheme that provides compensation under both a core and a supplementary route. Under the Infected Blood Compensation Scheme Regulations 2024, the Infected Blood Compensation Authority, or IBCA, has already made progress in paying infected people. As of 14 March, 255 people have been invited to start their compensation claim and 40 people have accepted their offers, totalling over £44 million. We recognise the scale of what needs to be done, and the Cabinet Office continues to work closely with IBCA to ensure that it works as quickly as possible to deliver compensation to people for whom it is long overdue.
The draft regulations will consolidate the 2024 regulations and establish the compensation scheme in full, including for people who are affected: those loved ones of people who are infected, defined in the draft regulations as partners, parents, children, siblings and, in some instances, carers. The draft regulations will allow IBCA to begin making payments to people who are affected by the end of this year.
The draft regulations will also establish the supplementary route, for exceptional cases in which compensation under the core route was not considered sufficient. The supplementary awards for infected people include an additional autonomy award, where someone was subjected to unethical research; a severe health condition award for financial loss and care, where someone suffered from a specific rare health condition that is likely to result in greater care needs or impact an infected person’s ability to work; and an exceptional loss award for financial loss and care, where someone can evidence additional financial loss, most likely as a result of being a higher earner or having higher care costs due to their infection.
There is also a supplementary financial loss award for affected people. This will provide compensation where an affected person was financially dependent on an infected person at the time of their death and that dependency has not already been recognised through the core route. The supplementary route has a higher evidential requirement; people who are claiming will need to demonstrate that their circumstances necessitate a higher compensation award. Importantly, the draft regulations will also allow for people to return to the scheme should their condition worsen as a result of their infection, and for people to claim multiple awards in the devastating circumstances that they are both infected and affected, or affected multiple times over.
I should acknowledge that the draft regulations also amend a small mathematical error that was present in the 2024 regulations. I apologise for this, and reassure the Committee that anyone affected by the issue will receive all the compensation they are due, and resolving the issue should not cause any delays in the roll-out of compensation. The error is a result of the mathematical formula used to calculate some people’s financial loss and care award in the 2024 regulations. To be clear, that means that some people who have been made an offer were offered slightly less than was intended. It will impact only a relatively small number of around 50 people who have received their offer of compensation from IBCA, and the discrepancy represents less than 1% of the claim amount. However, it is important that I draw this to the attention of Members.
Once the problem was identified, we worked quickly to identify a solution to ensure no one was negatively impacted. IBCA has reached out to claimants today to inform them of the error. In addition to IBCA ensuring that everyone receives the correct amount of compensation, the people who were impacted by this will also receive a small ex gratia payment. I want to reassure Members that steps were taken quickly and the draft regulations have been reviewed thoroughly to ensure that the error has been properly addressed. I also highlight that a small amendment was made to today’s draft statutory instrument after it was laid to correct a very minor typographical mistake. Just to reassure Members, I note that the sub-paragraphs were (a) (b) (b) instead of (a) (b) (c), and there was an unnecessary comma. I reassure everyone that those errors have been corrected.
I recently visited the IBCA team, led by Sir Robert Francis, and I know how determined they are for compensation to be paid out to victims as soon as possible. Nothing can ever undo the decades of injustice, pain and suffering, but the draft regulations are another step towards providing full and fair compensation to the people impacted by the infected blood scandal, who have already waited too long for justice. We, as a Government, and more widely as a party and as parliamentarians, should not rest until we see this delivered. We will work closely with IBCA to ensure that it prioritises providing payments quickly, efficiently and in a way that puts the people it is delivering for at the heart of its work. I look forward to hearing Members’ contributions.
Nick Thomas-Symonds
I am grateful for both those contributions. I repeat on record my tribute to my predecessor as Paymaster General, the right hon. Member for Salisbury. When I was in opposition, I always sought to work on a constructive, cross-party basis. I say to the shadow Minister, the hon. Member for Kingswinford and South Staffordshire, that I am pleased to see that continuing today. That does not mean that the Opposition do not ask appropriate and searching questions—of course they do—but that cross-party support is really important for the signal we send to the infected blood victims and for the delivery of this scheme, as we stand behind IBCA.
On the questions posed by the former Paymaster General, he will know that, during the general election campaign, when he and I were on various doorsteps around the country, Sir Robert Francis carefully conducted a consultation exercise with the victims. The first thing I found on my desk when I went into Whitehall was a report with 74 recommendations about changes to the scheme. Had the previous Government been re-elected, the document would have been waiting for the right hon. Gentleman. I accepted 69 of the 74 recommendations, including on the continuation of the regular payments and the payment of a lump sum. A significant set of changes were made to the scheme.
I am pleased that the right hon. Gentleman has visited IBCA and seen the work that is going on. I encourage the shadow Minister and other Members of Parliament with an interest in this matter to visit it to see that work. In the other place, Baroness Anderson undertook to place the “Infected Blood Compensation— Getting it Right” document that the right hon. Gentleman referenced in the House Library so that everybody can see it. I support her undertaking.
The right hon. Gentleman is entirely correct that IBCA is an operationally independent arm’s length body. That is what it is set up to be. That is how it will conduct its day-to-day business. As the Minister, I stand ready to help and assist in any way I can to speed up the payments. I am restless for the speed of delivery to increase, but I respect that operational independence going forward, as it is important that I do.
To the point made by the right hon. Gentleman around myths and misinformation, which I am afraid are just a fact of life in the age of social media, it is important for hon. and right hon. Members to go to IBCA’s website and see the newsletters and updates that it publishes on payments. We must also ensure that that is on the Government website, and I take the view that publishing things and putting them in the public domain is by far the better way to go. I will come to the issue the shadow Minister raised about tariffs in a minute, but the explanations for the decisions the Government have made are there in the documents on the website. I say to hon. and right hon. Members that they should go to them so that they can best assist constituents who raise questions.
The point about speed is important. IBCA is adopting a “test and learn” approach. In other words, it has a set of cases that are representative of the general body of cases for which it is paying out. That means that there should be—the right hon. Member for Salisbury referred to it as a hockey stick, which is essentially what it is—an exponential growth in payments. I am as restless as anybody in this room to get to that vertical part of the hockey stick as soon as possible.
To the shadow Minister’s point about money, we will make available the money that is required. We have already made that £11.8 billion available. He also asked a really good question about the level of evidence, and we recognise two things in that respect. First, so much of this happened a very long time ago now—particularly the importation of infected blood, which obviously ceased a long time ago. Secondly, we know from Sir Brian Langstaff’s report that there was deliberate document destruction. Those two things have to be taken into account in terms of evidence.
What I found at IBCA was that there will be that caseworker—that person—for each of these cases. What I also saw was the culture that Sir Brian Langstaff is insisting staff adopt, which is an enabling culture—a helpful culture. Many factors in particular cases are important, including whether someone was a carer or where people lived at the relevant point. People will have that sympathetic, enabling approach of asking what types of evidence might be helpful and where it could be obtained from.
Let me deal with the points about the framework document and about hepatitis C and hepatitis B versus HIV. First, the framework document sets out the timelines agreed between IBCA and the Cabinet Office. The bulk of infected people are to be paid by the end of 2027, and the bulk of affected people are to be paid by the end of 2029, but let me just make it clear that those are not targets: it is as soon as possible and not later than those dates.
John Glen
I can say this now: it is quite frustrating when, as a Minister, you are given those dates and you know that the significant likelihood and probability is that it will be faster than that, but you are not permitted to say so, because you cannot give false hope. I know the Paymaster General is seeking to move those to the left at every opportunity, but his wonderful officials will be constraining him and giving him some concerns around doing so.
Nick Thomas-Symonds
The right hon. Gentleman has particular insight into the workings of the Cabinet Office. Like everyone in the room, he and I are restless for progress. We want these payments out of the door as soon as possible.
The shadow Minister raised the issue of HIV, on the one hand, and hepatitis B and C, on the other. In terms of our tariff rates for hepatitis C, the impact of a hepatitis infection can obviously range from very mild to very severe, through to liver failure and death, as a direct result of the infection. The expert group—appointed by the right hon. Member for Salisbury—provided the Government with clinical advice on the distinctions between those impacts. That meant that we could set severity bands for hepatitis based on clear clinical markers. Therefore, where someone’s experience of hepatitis—whether historical or now—has been more severe, they will get more compensation.
The expert group also recommended a single severity band for those infected with HIV. Sadly, most people infected with HIV due to infected blood have already died, and in most cases the death was as a result of that HIV infection. Those who survived will continue to be severely impacted by their infection. The view of the expert group, which the Government accepted, is that it is disproportionately complex to break down the HIV category into different severity bands. That is why there is a distinction in the bands.
The shadow Minister rightly asked about affected estates. As he indicated, the Government are following Sir Brian Langstaff’s recommendation about how widely we draw the circle. Where an affected estate will have a claim is where there is a claim on a debt. What that means is that an offer was accepted while the affected person was alive. If there has been the offer and the acceptance, then the affected estate has a claim on the debt. We think that that is a reasonable place to draw the line, and it is in line with Sir Brian Langstaff’s recommendation.
I am grateful for both contributions to the debate. There is huge importance to getting this right. It is about achieving fair and comprehensive compensation that is simple enough to deliver quickly without diminishing the individual harm that people have faced. That is the purpose of a tariff-based scheme: it is to get that balance right between swiftness of delivery and not diminishing individual harm. As the shadow Minister will know, if we look at an infected person, there is the injury award, the social impact award, the autonomy award, the financial loss award and the care award, and indeed the core route and the supplementary route. It is a scheme that is trying to strike that balance.
No one is suggesting that this is a straightforward task, but if we look at the recommendations of the infected blood inquiry, at the work of Sir Robert Francis, the advice of the infected blood inquiry response expert group that was led so well by Sir Jonathan Montgomery— appointed by the right hon. Member for Salisbury—they have all made a significant contribution to where we are today. No amount of compensation will make up for the pain and suffering that the victims have faced, and the Government recognise that. Now, however, we need to focus on supporting the Infected Blood Compensation Authority, so I hope we get support for the draft regulations in a few moments; they will enable IBCA to provide that compensation swiftly and compassionately.
I welcome and thank all Members who are interested in this topic. I appreciate the cross-party work on seeking justice, but I also say to all Members present—just as the right hon. Member for Salisbury did—that the door is open for them to raise individual cases and issues with me. Members should please raise them with the Cabinet Office, and I will do my best to ensure that they get a swift response. I hope all colleagues will join me in supporting the draft regulations, and I commend them to the Committee.
Question put and agreed to.
Resolved,
That the Committee has considered the draft Infected Blood Compensation Scheme Regulations 2025.